My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

15.59 -0.13 (-0.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗

January 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 25, 2022

Good morning, investor! We're starting off the day right with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Why Amarin Stock Tumbled in November ↗

December 07, 2021

The biopharma's stock could be near a bottom after last month's double-digit decline.

Via The Motley Fool

Why Amarin Stock Crushed the Market on Tuesday ↗

November 16, 2021

An activist investor revealed that it held a small stake in the company.

Via The Motley Fool

Analyzing Amarin Corp's Unusual Options Activity ↗

August 11, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...

Via Benzinga

Analyzing Amarin Corp's Unusual Options Activity ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual opti...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Amarin Posts Encouraging Vascepa Data In Patients With Peripheral Artery Disease ↗

November 16, 2021

Amarin Corporation plc (NASDAQ: AMRN) reported new data for Vascepa/Vazkepa (icosapent ethyl) at the American Heart Association (AHA) Scientific Sessions. The...

Via Benzinga

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

Amarin (AMRN) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

AMRN earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More ↗

November 14, 2021

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...

Via Benzinga

Cramer Shares His Thoughts On Dynavax, Nucor And Amarin ↗

September 24, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Dynavax Technologies Corporation (NASDAQ: DVAX) is good. He loves the immuno drug stories. Cramer said you are...

Via Benzinga

Amarin Stock Moves Higher As Vascepa Cuts Risk Of Heart Attacks ↗

August 23, 2021

Amarin Corporation plc (NASDAQ: AMRN) announced additional data on Vascepa/Vazkepa (icosapent ethyl) in patients with prior heart attack, known as myocardial...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

Why Amarin Is Soaring Today ↗

August 05, 2021

The pharmaceuticals company is showing surprising resilience in the face of competition.

Via The Motley Fool

Topics Intellectual Property

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

Amarin (AMRN) Q2 2021 Earnings Call Transcript ↗

August 05, 2021

AMRN earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Amarin Q2 Earnings ↗

August 05, 2021

Shares of Amarin Corp (NASDAQ:AMRN) rose 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the...

Via Benzinga

Understanding Amarin Corp's Unusual Options Activity ↗

July 19, 2021

Shares of Amarin Corp (NASDAQ:AMRN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $4.22. Sentiment: BEARISH Option...

Via Benzinga

Why Amarin Fell Again Today ↗

June 22, 2021

Another Vascepa generic is launched in the U.S.

Via The Motley Fool

Topics Intellectual Property

48 Biggest Movers From Yesterday ↗

June 22, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal ↗

June 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide ↗

June 21, 2021

Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the...

Via Benzinga

Topics Stocks

31 Stocks Moving In Monday's Mid-Day Session ↗

June 21, 2021

Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...

Via Benzinga

Why Amarin Stock Is Sinking Today ↗

June 21, 2021

The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end.

Via The Motley Fool

Topics Intellectual Property

Understanding Amarin Corp's Unusual Options Activity ↗

June 09, 2021

Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type...

Via Benzinga

Market Briefing For Tuesday, Jun. 8 ↗

June 08, 2021

Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first.

Via Talk Markets

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.